Atlas FDA

SDJ

3 FDA 510(k) clearances · Product code

FDA profile

Official device name
Adjunctive Cardiac Amyloidosis Status Indicator
Device class
Class II (moderate risk)
Regulation
21 CFR 870.2200
Medical specialty
Cardiovascular
FDA definition
The adjunctive cardiac amyloidosis status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting cardiac amyloidosis. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Us2.ca (K250151)Eko.Ai Pte Ltd. D/B/A Us2.Ai2025-06-20
InVision Precision Cardiac Amyloid (K243866)InVision Medical Technology Corporation2025-05-21
EchoGo Amyloidosis (1.0) (K240860)Ultromics Limited2024-11-15

Track SDJ automatically

Every clearance here is in the API, with alerts when new ones post.